Pandemic-era cannabis increases linked to rising disorder symptoms in youth

Changes in Symptoms of Cannabis Use Disorder of Ontario Youth Across the COVID-19 Pandemic: A Longitudinal Cohort Study.

Substance use & addiction journal β€’ β€’ Highly Relevant
πŸ€–

AI Summary

This study asked whether young people who reported increasing their cannabis use during the COVID-19 pandemic also experienced changes in symptoms of cannabis use disorder (CUD). It followed 1,579 Ontario residents aged 16 to 30 who had used cannabis in the previous three months, using online surveys completed in 2022 and 2023. This was an observational cohort study, not a trial assigning cannabis exposure.

πŸ’‘ Key Findings

1
Reporting increased cannabis use during the pandemic was significantly associated with increased CUD symptom scores across the survey waves.
High
80%
2
The association between increased use and changes in CUD symptoms was stronger among younger participants than older participants.
Good
70%

πŸ“„ Original Abstract

BACKGROUND: Cannabis use increased among youth during the COVID-19 pandemic. However, there is a lack of research examining whether there were lasting changes in cannabis use and, in particular, problematic cannabis use, across the pandemic. This is particularly important to examine among young adults because problematic cannabis use is associated with a greater likelihood of impaired neurodevelopment and adverse health outcomes. METHODS: The study was a longitudinal cohort survey of Canadian youth (n = 1579; 55% female; mean age 22 years) aged 16 to 30 residing in Ontario who reported cannabis use in the past 3 months. Respondents completed online questionnaires regarding their cannabis use once in 2022 and again in 2023. Linear regression examined the association between reporting increased cannabis use during the pandemic and changes in symptoms of cannabis use disorder (CUD) (measured by the Cannabis Use Disorder Identification Test-Revised [CUDIT-R]). Models were adjusted for sociodemographic factors and psychological distress. RESULTS: Linear regression indicated that increased cannabis use in response to the COVID-19 pandemic was significantly associated with increased CUDIT-R scores across survey waves (Ξ²: 1.49; 95% CI: 0.99, 2.00). The association between increased cannabis use and changes in symptoms of CUD was stronger for younger than older participants (P = .04). CONCLUSION: The COVID-19 pandemic was associated with increasing symptoms of CUD, particularly among youth, even 3 years after it was initially declared. This study highlights the importance of addressing the ongoing impacts of the COVID-19 pandemic and developing strategies to prevent hazardous substance use in future health crises.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.